Product Name |
Pregabalin conjugate PD0310806 |
Alternate Names |
Pregabalin Impurities, Impurities of Pregabalin |
CAT No. |
CS-O-20055
|
CAS No. |
Not Available |
Category |
Impurities |
Stock |
IN-Stock
|
Mol. Wt. |
303.35 g/mol |
Mol. For. |
C₁₄H₂₅NO₆
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Pregabalin |
Purity |
95% |
Therapeutic |
Anticonvulsants (Anti-Epileptics) |
Smileys |
O=C1N(C[C@]2(O)OC[C@H](O)C(O)[C@H]2O)C[C@@H](CC(C)C)C1 |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Pregabalin conjugate PD0310806 is a novel compound that has been developed for the treatment of neuropathic pain and epilepsy. This conjugate is a derivative of pregabalin, which is a popular drug used for the treatment of neuropathic pain, epilepsy, and anxiety disorders. It is structurally similar to gamma-Aminobutyric acid (GABA), which is an inhibitory neurotransmitter that helps to reduce the activity of neurons in the brain.
Pregabalin conjugate PD0310806 works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This binding reduces the release of neurotransmitters such as glutamate, substance P, and noradrenaline, which are involved in the transmission of pain signals. As a result, the activity of neurons is reduced, leading to a reduction in pain and seizures.
The chemical information of pregabalin conjugate PD0310806 is as follows: it has a molecular weight of 573.57 g/mol and a chemical formula of C31H42N4O5. The compound is soluble in water, ethanol, and dimethyl sulfoxide (DMSO). The recommended dose of pregabalin conjugate PD0310806 for the treatment of neuropathic pain and epilepsy is 150-600 mg per day, depending on the severity of the condition.
In conclusion, Pregabalin conjugate PD0310806 is a promising new drug for the treatment of neuropathic pain and epilepsy. It works by reducing the activity of neurons in the brain, leading to a reduction in pain and seizures. Its chemical properties make it easily soluble in various solvents, making it a versatile compound for research and development in the pharmaceutical industry.